Research Article
Comparison of Perioperative, Functional, and Oncological Outcomes of Transperitoneal and Extraperitoneal Laparoscopic Radical Prostatectomy
Table 1
Demographics and clinical characteristics of the study population between extraperitoneal and transperitoneal approach.
| | Characteristics | Group 1: E-LRP (n = 168) | Group 2: T-LRP (n = 98) | value |
| | Age (years, mean ± SD) | 68.4 (6.1) | 69.1 (6) | 0.346 | | BMI (median, IQR) | 24 (22.9, 26.5) | 24.8 (22.6, 26.3) | 0.811 | | Charlson Comorbidity Index | 1 (0–6) | 1 (0–7) | 0.81 | | PSA (ng/mL) | 12.5 (8.1, 22.9) | 16.6 (10.7, 24.4) | 0.005 | | Clinical T stage-n (%) | | | 0.095 | | 1b-2a | 14 (8.3) | 13 (13.3) | | | 2b | 11 (6.5) | 8 (8.2) | | | 2c | 98 (58.3) | 40 (40.8) | | | 3a | 14 (8.3) | 15 (15.3) | | | 3b | 30 (17.9) | 22 (22.4) | | | 4 | 1 (0.6) | 0 (0) | | | Gleason score-n (%) | | | 0.228 | | 6 (3 + 3) | 62 (36.9) | 23 (23.5) | | | 7 (3 + 4) | 45 (26.8) | 33 (33.7) | | | 7 (4 + 3) | 37 (22) | 24 (24.5) | | | 8 (4 + 4) | 10 (6) | 6 (6.1) | | | 9 (5 + 4) | 14 (8.3) | 12 (12.2) | | | Nerve sparing (NS) | | | 0.448 | | Non | 145 (86.3) | 79 (80.6) | | | Unilateral | 19 (11.3) | 15 (15.3) | | | Bilateral | 4 (2.4) | 4 (4.1) | |
|
|
PSA: prostatic specific antigen and BMI: body mass index.
|
